Agency Links:    Home   Contact Us    Compliments & Complaints   Help    Site Map
Link to Homepage

Patient/Public Info  |  Regional Services  |  Health Professionals Info  |  About BCCA  |  Research  |  Donating

3.4 Staging

Revised November 2008

1) Clinico pathologic Considerations

Gross Description

Gross description of the hysterectomy specimen should include:
a) in a polyp or not
b) location of the tumour withing the uterus
c) the depth of mymetrial invasion (luminal or serosal half)
d) the presence or absence of cervial involvement

Microscopic Description

a)

The histologic type

b)

The histologic grade (1-3)

c)

Myometrial invasion if present

 

i) Luminal half

 

ii) Serosal half

d)

The presence or absence of lymphatic or vascular invasion and degree

e)

Perilymphatic inflammation (slight, moderate, marked)

f)

Cervical involvement (mucosal extension or stromal involvement)

g)

Lymph node involvement

h)

Adnexal involvement

i)

Cytology of peritoneal fluid


2) Staging Diagram

Corpus uteri.pdf  

3) Preoperative Investigations for Staging

  • chest x-ray
  • endocervical curretage
  • imaging with CT or U/S as appropriate
  • rarely some patients may need cystoscopy or sigmoidoscopy
  • tumour markers: CA 125, CA 19-9, CA15-3, CEA